Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 91151-91200 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05165069
The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome
PHASE3Active, not recruiting
234 participants
Started: Jan 1, 2022 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT04647162
A Clinical Trial About the Safety of Surgical Treatment in Severe Primary Pontine Hemorrhage
NARecruiting
64 participants
Started: Jan 1, 2022 · Completed: Nov 30, 2024
4 conditions1 sponsor20 locations
NCT05245487
Danish Elder Lymphoma Patient Hematopoietic Investigation
N/ARecruiting
300 participants
Started: Jan 1, 2022 · Completed: Jan 1, 2035
4 conditions9 sponsors1 location
NCT05450029
Neoadjuvant Chemoradiotherapy Plus Sintilimab for Intermediate/High Immunoscore Locally Advanced Rectal Cancer
PHASE2Recruiting
51 participants
Started: Jan 1, 2022 · Completed: Jan 1, 2027
1 condition2 sponsors1 location
NCT05928364
Buccal Mucosal Graft for Onlay Ureteroplasty in the Management of Proximal Ureteral Stricture
NARecruiting
100 participants
Started: Jan 1, 2022 · Completed: Oct 1, 2024
1 condition1 sponsor1 location
NCT05151523
Long-term Recurrence Rates of Atrial Fibrillation Following New-onset Atrial Fibrillation During ICU Admission
N/ANot yet recruiting
100 participants
Started: Jan 1, 2022 · Completed: Dec 1, 2026
1 condition1 sponsor0 locations
NCT05322824
Clinical Registration Study of Patients With Intracranial / Carotid Stenosis
N/ARecruiting
500 participants
Started: Jan 1, 2022 · Completed: Dec 31, 2029
2 conditions1 sponsor1 location
NCT05646745
Autologous Transobturator Fascia Lata Sling in Treatment of Female Stress Urinary Incontinence
NARecruiting
60 participants
Started: Jan 1, 2022 · Completed: Jan 1, 2026
1 condition1 sponsor2 locations
NCT05042505
Effect of Dapagliflozin vs Sitagliptin on Liver Fat Accumulation and Body Composition in Patients With Diabetes Mellitus and Liver Transplantation
NARecruiting
100 participants
Started: Jan 1, 2022 · Completed: Nov 1, 2025
2 conditions1 sponsor1 location
NCT06095700
First Rib Resection Versus Avulsion for Thoracic Outlet Syndrome
NARecruiting
50 participants
Started: Jan 1, 2022 · Completed: Jun 1, 2024
1 condition1 sponsor1 location
NCT06114602
Impact of Email Reminders on No-Show Rates for Appointments in an Urology Department
N/ARecruiting
1,892 participants
Started: Jan 1, 2022 · Completed: Mar 30, 2024
2 conditions1 sponsor1 location
NCT05283239
Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection
N/ARecruiting
1,000 participants
Started: Jan 1, 2022 · Completed: Dec 31, 2024
4 conditions1 sponsor11 locations
NCT06100718
Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study
N/ARecruiting
370 participants
Started: Jan 1, 2022 · Completed: Dec 31, 2025
6 conditions1 sponsor3 locations
NCT05218278
NFL Dynamics as a Predictor Factor in Patients With Out of Hospital Cardiac Arrest
N/ARecruiting
60 participants
Started: Jan 1, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04963426
Empowering Adolescents to Lead Change Using Health Data
NARecruiting
12,612 participants
Started: Jan 1, 2022 · Completed: Jan 31, 2027
1 condition4 sponsors5 locations
NCT05638750
Outpatient Rehabilitation Intervention for Young Children With SMA
NARecruiting
10 participants
Started: Jan 1, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05426720
Risk Factors and Biomarkers for Post-tuberculosis Lung Damage
N/ARecruiting
400 participants
Started: Jan 1, 2022 · Completed: Dec 31, 2027
1 condition2 sponsors2 locations
NCT04813705
18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma
PHASE2Recruiting
93 participants
Started: Jan 1, 2022 · Completed: Jun 30, 2029
1 condition3 sponsors4 locations
NCT04976426
Establishment and Clinical Validation of a New Technique for Early Diagnosis of Diabetic Nephropathy
N/ANot yet recruiting
1,000 participants
Started: Jan 1, 2022 · Completed: Dec 31, 2026
4 conditions3 sponsors0 locations
NCT05166070
An Exploratory Clinical Study of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors
EARLY_PHASE1Recruiting
24 participants
Started: Jan 1, 2022 · Completed: Jan 1, 2037
1 condition2 sponsors1 location
NCT06129227
Brain Activity Changes After Structured Cognitive-motor Exercise for People With Stroke
NARecruiting
84 participants
Started: Jan 1, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06359132
mHealth Rhythm Management in Terms of Cancelling Unnecessary Scheduled ECVs in Presumed Persistent AFpatients.
N/ARecruiting
264 participants
Started: Jan 1, 2022 · Completed: Jan 1, 2025
4 conditions1 sponsor2 locations
NCT05572528
Lenvatinib Therapy in HCC Patients After LDLT
N/ARecruiting
30 participants
Started: Jan 1, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05238181
Pyloric or Pseudopyloric Metaplasia of the Corpus Mucosa in Autoimmune Gastritis
N/AEnrolling by invitation
300 participants
Started: Jan 1, 2022 · Completed: Dec 31, 2024
5 conditions2 sponsors1 location
NCT05700565
Treatment of Immune-related Adverse Events Refractory to Standard Therapy and Associated Changes in Immunophenotype
N/ARecruiting
50 participants
Started: Jan 1, 2022 · Completed: Jan 1, 2027
1 condition1 sponsor1 location
NCT05408897
Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD
N/ARecruiting
45 participants
Started: Jan 1, 2022 · Completed: Apr 30, 2028
2 conditions1 sponsor1 location
NCT04699799
Characterization of Human Olfactory Amygdala Subregions
NARecruiting
100 participants
Started: Jan 1, 2022 · Completed: Apr 1, 2026
1 condition1 sponsor1 location
NCT05132985
Neoadjuvant Icotinib With Chemotherapy for Epidermal Growth Factor Receptor(EGFR)-Mutated Resectable Lung Adenocarcinoma
PHASE2Not yet recruiting
45 participants
Started: Jan 1, 2022 · Completed: Jan 1, 2028
2 conditions1 sponsor1 location
NCT05607368
Mast Cells Are Involved in the Mechanism of NPSLE Epilepsy
N/ARecruiting
45 participants
Started: Jan 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05214612
Predictors and Prognostic Factors of Myasthenia Gravis Outcome
N/ARecruiting
30 participants
Started: Jan 1, 2022 · Completed: Mar 31, 2025
12 conditions1 sponsor1 location
NCT06345521
Etablishment of Follow-up System and End-Stage Heart Registration Platform for Pediatric Heart Failure
N/ARecruiting
100 participants
Started: Jan 1, 2022 · Completed: Dec 31, 2024
3 conditions3 sponsors1 location
NCT05494021
China Lung Cancer Screening (CLUS) Study Version 3.0
NARecruiting
100,000 participants
Started: Jan 1, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06569420
Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC
PHASE3Active, not recruiting
275 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT05183958
A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal Cancer
PHASE2Not yet recruiting
118 participants
Started: Dec 31, 2021 · Completed: Dec 1, 2025
1 condition9 sponsors1 location
NCT05527704
the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)
PHASE3Recruiting
608 participants
Started: Dec 31, 2021 · Completed: Sep 30, 2026
3 conditions9 sponsors1 location
NCT05165316
European Long-acting Antipsychotics in Schizophrenia Trial-II
N/AEnrolling by invitation
400 participants
Started: Dec 31, 2021 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT03423511
Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries.
NANot yet recruiting
1,300 participants
Started: Dec 31, 2021 · Completed: Jun 1, 2027
1 condition4 sponsors0 locations
NCT05122169
Skip Prep of Vaginal Delivery to Prevent Puerperal / Perinatal Infection in Vaginal Delivery
NANot yet recruiting
4,140 participants
Started: Dec 31, 2021 · Completed: May 31, 2026
2 conditions1 sponsor0 locations
NCT05226507
A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer
PHASE1Active, not recruiting
45 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2025
8 conditions3 sponsors22 locations
NCT05105321
Cardiovascular Diseases and Diabetes Prevention Programme in Metabolic Syndrome (CDPP)
PHASE4Not yet recruiting
5,200 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT05043181
Exosome-based Nanoplatform for Ldlr mRNA Delivery in FH
PHASE1Not yet recruiting
30 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05541367
Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer
N/ARecruiting
80 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT06192290
Home-based Transitional Telerehabilitation in Cardiac Recovery
NARecruiting
118 participants
Started: Dec 31, 2021 · Completed: Feb 1, 2024
2 conditions1 sponsor1 location
NCT05277272
INTO-HLH: A Disease Registry for Patients With Hemophagocytic Lymphohistiocytosis (HLH)
N/ARecruiting
200 participants
Started: Dec 31, 2021 · Completed: Jan 31, 2026
1 condition3 sponsors1 location
NCT05595226
Effect of RT3D-TEE-guided Mitral Valve Repair on Outcomes in Patients With Degenerative Mitral Valve Disease
NARecruiting
338 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05178056
Spinal Cord Stimulation and Respiration After Injury
NARecruiting
30 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2030
4 conditions2 sponsors1 location
NCT04822766
A Study Comparing Allogeneic Hematopoietic Cell Transplantation Versus Best Available Standard of Care Therapy in Elderly Patients With Acute Myeloid Leukemia
NAActive, not recruiting
24 participants
Started: Dec 31, 2021 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT05167851
The Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer
PHASE2Not yet recruiting
68 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04885985
ACOART BTK RENEW:A Post Market Clinical Study
NARecruiting
107 participants
Started: Dec 31, 2021 · Completed: Apr 1, 2027
1 condition1 sponsor1 location
NCT05179551
Achillestendinopathy Treated With Proximal Medial Gastrocnemius Recession
NARecruiting
60 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2025
2 conditions2 sponsors2 locations